Overview

A Study of Marstacimab to Compare Prefilled Pen (PFP) Device to Prefilled Syringe (PFS) Device

Status:
Suspended
Trial end date:
2022-01-06
Target enrollment:
Participant gender:
Summary
The goal in this study is to show that there are not significant differences in biologic activity of the study drug when administered using either the prefilled pen and prefilled syringe.
Phase:
Phase 1
Details
Lead Sponsor:
Pfizer